Anti-SARS-CoV S/Spike glycoprotein Recombinant Nanobody (SAA1322) (VK593013)

Datasheet Share product Copy info

Price(USD): $

Spec:

50ug
100ug
1mg

Number:

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.

VK593013

Description

Anti-SARS-CoV S/Spike glycoprotein Nanobody (SAA1322) [SAA1322] (VK593013) is a alpaca monoclonal antibody detecting Spike glycoprotein in ELISA, Neutralization, SPR.

Highlights

●Multi-Application — Validated across multiple applications.

Species reactivity

Severe acute respiratory syndrome coronavirus (SARS-CoV)

Applications

ELISA, Neutralization, SPR

Host species

Alpaca

Isotype

VHH-8His-Cys-tag

Clone ID

SAA1322

Clonality

Monoclonal

Target

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Nickel column.

Accession

P59594

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:2000-1:20000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Background

Spike glycoprotein is a ~139 kDa protein. May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity.

Note

For research use only.

Images